Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present two oral ...
The global pulmonary drug delivery systems market was US$ 53267.55 in 2021. The global pulmonary drug delivery systems market is forecast to reach US$ 91,128.65 million by 2030, growing at a compound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback